Cutera (CUTR) Scheduled to Post Earnings on Thursday

Cutera (NASDAQ:CUTR) will release its earnings data after the market closes on Thursday, November 7th. Analysts expect Cutera to post earnings of ($0.86) per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

Cutera (NASDAQ:CUTR) last released its quarterly earnings data on Thursday, August 8th. The medical device company reported ($1.23) earnings per share for the quarter, beating the consensus estimate of ($1.55) by $0.32. The business had revenue of $34.38 million during the quarter, compared to analyst estimates of $39.47 million. On average, analysts expect Cutera to post $-5 EPS for the current fiscal year and $-4 EPS for the next fiscal year.

Cutera Stock Down 4.9 %

NASDAQ:CUTR opened at $0.56 on Tuesday. The stock’s 50-day simple moving average is $0.71 and its 200 day simple moving average is $1.34. The firm has a market capitalization of $11.23 million, a PE ratio of -0.08 and a beta of 1.35. Cutera has a twelve month low of $0.55 and a twelve month high of $4.97.

Analyst Ratings Changes

Several analysts have recently weighed in on CUTR shares. Stephens reduced their price target on Cutera from $10.00 to $5.00 and set an “overweight” rating on the stock in a report on Friday, August 9th. Piper Sandler restated a “neutral” rating and set a $1.00 price target (down from $3.00) on shares of Cutera in a report on Friday, August 9th. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $5.33.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.